Position in DNLI
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,532,912
+$691,952 QoQ
Shares Held
59,600
+36.1% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#106
of 290 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. DNLI ranks #48 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
218,292 | $108,432,185 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
631,899 | $49,458,734 | |
| 3 | ARGX |
Argenx SE
|
52,653 | $48,849,873 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
212,275 | $39,754,862 | |
| 5 | CYTK |
Cytokinetics Inc
|
405,000 | $34,501,950 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
90,407 | $33,601,569 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,328 | $32,628,601 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
107,255 | $32,286,972 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,532,912 | 59,600 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $840,960 | 43,800 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $723,138 | 43,800 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $556,116 | 38,300 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $535,817 | 38,300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $520,688 | 38,300 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $780,554 | 38,300 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,150,635 | 39,500 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $917,190 | 39,500 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $490,428 | 23,900 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $512,894 | 23,900 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $354,836 | 17,200 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $507,572 | 17,200 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $324,864 | 14,100 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $392,121 | 14,100 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $411,246 | 13,400 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $394,362 | 13,400 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $379,606 | 11,800 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $802,800 | 18,000 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $908,100 | 18,000 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,411,920 | 18,000 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,039,220 | 18,200 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,181,016 | 14,100 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $505,203 | 14,100 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $340,938 | 14,100 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||